[1]Actapoloniaepharmaceutica,2015,vol.72,p.79-87
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
40052-63-9 | 2-Bromo-N-methylethanamine hydrobromide | AA00C6V6 | MFCD09953007
36057-46-2 | 5-Bromo-3-methoxy-pyridine 2-carbonitrile | AA00C72E | MFCD11857636
39736-29-3 | Ethyl 4-amino-2-(methylthio)-1,3-thiazole-5-carboxylate | AA00C7AU | MFCD01830310
34784-06-0 | 7-Chloroisoquinoline | AA00C7I6 | MFCD00094995
33976-43-1 | M-AMINOPHENYLTRIMETHOXYSILANE | AA00C7MV | MFCD00054700
3228-27-1 | FORMALDEHYDE (13C) | AA00C7XL | MFCD00144372
406-30-4 | 1,1,1-TRIFLUORO-2,3-EPOXYBUTANE | AA00C821 | MFCD00236721
40019-65-6 | 2-(2-Chloro-1h-benzimidazol-1-yl)ethanol | AA00C874 | MFCD04336120
366-44-9 | 2-Chloro-n-(4-fluoro-2-methylphenyl)acetamide | AA00C8B2 | MFCD08077753
42245-37-4 | 3-Methylpentan-1-amine | AA00C8F4 | MFCD08059958